Mesenchymal Stromal Cell Dependent Regression of Pulmonary Metastasis from Ewing's
Introduction: Ewing’s sarcoma (ES) is the second most common bone tumor in children. Survival has not improved over the last decade and once pulmonary metastatic disease is present, survival is dismal. Mesenchymal stromal cell (MSC) therapy has shown potential benefit for Kaposi's sarcoma; ho...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-05-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fped.2014.00044/full |